Renaissance Technologies »

Eliem Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 11k 2.73
2023-12-31 $29k 11k 2.74

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Amazon (AMZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Verisign (VRSN)
Uber Technologies (UBER)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Chipotle Mexican Grill (CMG)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Exelixis (EXEL)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Renaissance Technologies

Top funds holding Eliem Therapeutics

RA Capital Management
BML Capital Management
Driehaus Capital Management
Vanguard Group
Atom Investors
Geode Capital Management
Bridgeway Capital Management
Northern Trust
BlackRock
Tudor Investment Corporation
State Street Corporation
Millennium Management
Chicago Partners Investment
Renaissance Technologies
Advisor Group Holdings

View all funds holding Eliem Therapeutics